- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Blue
Recent news which mentions Blue
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
October 30, 2023
From Motley Fool
Cautious Optimism For Bluebird Bio's Sickle Cell Therapy: Analyst Sees Financial Challenges
October 17, 2023
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023
October 17, 2023
From Benzinga
Cathie Wood Is Buying This Growth Stock Hand Over Fist Lately. Should You Follow Her Lead?
October 03, 2023
From Motley Fool
Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
September 26, 2023
From Benzinga
Better Growth Stock: CRISPR Therapeutics vs. Bluebird Bio
September 20, 2023
From Motley Fool
1 Huge Risk That Gene-Editing Stock Investors Desperately Need to Know
September 19, 2023
From Motley Fool
More Likely to 5x First: Bluebird Bio vs. CRISPR Therapeutics
September 12, 2023
From Motley Fool
2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall Street
September 12, 2023
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
September 06, 2023
From Benzinga
Wall Street Thinks This Tiny Biotech Company Could Soar Soon
August 28, 2023
From Motley Fool
1 Beaten-Down Growth Stock You'd Regret Not Buying on the Dip, According to Wall Street
August 24, 2023
Tickers
BLUE
From Motley Fool
7 Very Oversold Nasdaq Stocks to Buy Right Now
August 23, 2023
From InvestorPlace
From Benzinga
2 Magnificent Growth Stocks I'm Buying Hand Over Fist Right Now
August 08, 2023
From Motley Fool
Tickers
BLUE
From Motley Fool
3 Stocks to Buy for Lottery Jackpot Style Returns
July 27, 2023
From InvestorPlace
3 Small-Cap Stocks That Could Be Big-Time Winners
July 22, 2023
From Motley Fool
From Benzinga
Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 19, 2023
From Benzinga
From Benzinga
Why Bluebird Bio Stock Is Taking Flight Today
July 19, 2023
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.